title: High affinity group III mGluRs regulate mossy fiber input to CA3 interneurons.
abstract: Stratum lacunosum-moleculare interneurons (L-Mi) in hippocampal area CA3 target the apical dendrite of pyramidal cells providing feedforward inhibition. Here we report that selective activation of group III metabotropic glutamate receptors (mGluRs) 4/8 with L(+)-2-amino-4-phosphnobytyric acid (L-AP4; 10 μM) decreased the probability of glutamate release from the mossy fiber (MF) terminals synapsing onto L-Mi. Consistent with this interpretation, application of L-AP4 in the presence of 3 mM strontium decreased the frequency of asynchronous MF EPSCs in L-Mi. Furthermore, the dose response curve showed that L-AP4 at 400 μM produced no further decrease in MF EPSC amplitude compared with 20 μM L-AP4, indicating the lack of mGluRs 7 at these MF terminals. We also found that one mechanism of mGluRs 4/8-mediated inhibition of release is linked to N-type voltage gated calcium channels at MF terminals. Application of the group III mGluR antagonist MSOP (100 μM) demonstrated that mGluRs 4/8 are neither tonically active nor activated by low and moderate frequencies of activity. However, trains of stimuli to the MF at 20 and 40 Hz delivered during the application of MSOP revealed a relief of inhibition of transmitter release and an increase in the overall probability of action potential firing in the postsynaptic L-Mi. Interestingly, the time to first action potential was significantly shorter in the presence of MSOP, indicating that mGluR 4/8 activation delays L-Mi firing in response to MF activity. Taken together, our data demonstrate that the timing and probability of action potentials in L-Mi evoked by MF synaptic input is regulated by the activation of presynaptic high affinity group III mGluRs.
authors.affiliation: Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA.
authors.forename: Kathleen E
authors.initials: KE
authors.lastname: Cosgrove
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Meriney
authors.forename: Germán
authors.initials: G
authors.lastname: Barrionuevo
mesh_terms: D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000613:Aminobutyrates / Q000494:pharmacology; D000818:Animals; D056654:CA3 Region, Hippocampal / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D003521:Cyclopropanes / Q000494:pharmacology; D004558:Electric Stimulation; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D007395:Interneurons / Q000187:drug effects / Q000502:physiology*; D008297:Male; D019599:Mossy Fibers, Hippocampal / Q000187:drug effects / Q000502:physiology*; D018408:Patch-Clamp Techniques; D010768:Phosphoserine / Q000494:pharmacology; D017966:Pyramidal Cells / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018094:Receptors, Metabotropic Glutamate / Q000187:drug effects / Q000502:physiology*; D017661:Receptors, Presynaptic / Q000187:drug effects / Q000502:physiology*
chemical_list: D000613:Aminobutyrates; D003521:Cyclopropanes; D018094:Receptors, Metabotropic Glutamate; D017661:Receptors, Presynaptic; C111435:metabotropic glutamate receptor 8; C120877:methylserine phosphate; C082313:2-(2,3-dicarboxycyclopropyl)glycine; D010768:Phosphoserine; C012729:2-amino-4-phosphonobutyric acid; D005998:Glycine; C108823:metabotropic glutamate receptor 4
references.citation: J Pharmacol Exp Ther. 2001 Oct;299(1):12-20
references.pmid: 11561058
references.citation: J Neurophysiol. 1996 Dec;76(6):3798-806
references.pmid: 8985877
references.citation: J Neurosci. 1988 Apr;8(4):1400-10
references.pmid: 3357023
references.citation: J Comp Neurol. 2009 Aug 20;515(6):677-95
references.pmid: 19496174
references.citation: Neuropharmacology. 1995 Aug;34(8):965-71
references.pmid: 8532177
references.citation: Eur J Neurosci. 2004 May;19(10):2847-58
references.pmid: 15147318
references.citation: J Comp Neurol. 1999 Apr 28;407(1):33-46
references.pmid: 10213186
references.citation: Mol Pharmacol. 1994 Mar;45(3):367-72
references.pmid: 8145723
references.citation: J Physiol. 2005 Jun 15;565(Pt 3):885-96
references.pmid: 15845577
references.citation: Science. 1996 Oct 25;274(5287):594-7
references.pmid: 8849448
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12004-9
references.pmid: 9751780
references.citation: J Physiol. 2004 Jan 1;554(Pt 1):175-93
references.pmid: 14678500
references.citation: Neuropharmacology. 2005;49 Suppl 1:45-56
references.pmid: 15998525
references.citation: Science. 1998 Feb 27;279(5355):1368-70
references.pmid: 9478900
references.citation: J Physiol. 1996 Jun 1;493 ( Pt 2):447-55
references.pmid: 8782108
references.citation: J Neurosci. 2008 Dec 24;28(52):14042-55
references.pmid: 19109487
references.citation: Nat Neurosci. 2002 Aug;5(8):790-5
references.pmid: 12118256
references.citation: J Neurosci. 1997 Oct 1;17(19):7503-22
references.pmid: 9295396
references.citation: Mol Pharmacol. 1997 Jan;51(1):119-25
references.pmid: 9016353
references.citation: Annu Rev Pharmacol Toxicol. 1997;37:205-37
references.pmid: 9131252
references.citation: Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):18004-9
references.pmid: 19815518
references.citation: J Comp Neurol. 1995 Oct 2;360(4):555-70
references.pmid: 8801249
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13304-9
references.pmid: 8917586
references.citation: Nature. 1997 Feb 13;385(6617):630-4
references.pmid: 9024660
references.citation: Neuron. 2006 Nov 9;52(3):497-510
references.pmid: 17088215
references.citation: Results Probl Cell Differ. 2008;44:163-75
references.pmid: 17579817
references.citation: Neuropharmacology. 1995 Nov;34(11):1549-57
references.pmid: 8606802
references.citation: J Neurochem. 2000 Sep;75(3):889-907
references.pmid: 10936169
references.citation: J Neurosci. 1996 Mar 15;16(6):2044-56
references.pmid: 8604049
references.citation: J Biol Chem. 2001 Dec 21;276(51):47877-85
references.pmid: 11604405
references.citation: J Neurosci. 2005 Nov 9;25(45):10520-36
references.pmid: 16280590
references.citation: J Neurosci. 1993 Apr;13(4):1372-8
references.pmid: 8463825
references.citation: J Neurophysiol. 2003 Apr;89(4):1910-9
references.pmid: 12686572
references.citation: J Neurosci. 2000 Nov 15;20(22):8279-89
references.pmid: 11069934
references.citation: J Neurosci. 2007 Dec 5;27(49):13420-9
references.pmid: 18057200
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14708-13
references.pmid: 11734656
references.citation: J Physiol. 2000 May 15;525 Pt 1:41-51
references.pmid: 10811723
references.citation: Br J Pharmacol. 2003 Feb;138(4):614-25
references.pmid: 12598415
references.citation: Nature. 2002 Jan 17;415(6869):327-30
references.pmid: 11797010
references.citation: Curr Neuropharmacol. 2005 Oct;3(4):299-307
references.pmid: 18369399
references.citation: Nat Neurosci. 1998 Nov;1(7):572-8
references.pmid: 10196564
references.citation: J Neurophysiol. 1994 Jun;71(6):2217-35
references.pmid: 7931512
references.citation: Neuroscience. 2002;110(3):403-20
references.pmid: 11906782
references.citation: Cell Tissue Res. 2006 Nov;326(2):483-504
references.pmid: 16847639
references.citation: Hippocampus. 1993 Apr;3(2):165-82
references.pmid: 8353604
references.citation: J Neurosci. 1997 Nov 1;17(21):8137-46
references.pmid: 9334389
references.citation: J Neurophysiol. 2006 Jul;96(1):86-96
references.pmid: 16611839
references.citation: J Neurosci. 2010 Feb 24;30(8):2844-55
references.pmid: 20181582
references.citation: Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12942-6
references.pmid: 7809151
references.citation: Brain Res Brain Res Rev. 1999 Jan;29(1):83-120
references.pmid: 9974152
references.citation: Pharmacol Ther. 2005 Jan;105(1):69-84
references.pmid: 15626456
references.citation: Neuron. 2005 Apr 7;46(1):89-102
references.pmid: 15820696
references.citation: J Physiol. 1993 Dec;472:615-63
references.pmid: 7908327
references.citation: Prog Neurobiol. 2002 Oct;68(3):167-207
references.pmid: 12450487
references.citation: J Physiol. 2008 Jun 1;586(11):2695-712
references.pmid: 18388134
references.citation: J Neurosci Methods. 2006 Jun 30;154(1-2):1-18
references.pmid: 16554092
references.citation: Cereb Cortex. 2004 Jul;14(7):748-58
references.pmid: 15054054
references.citation: J Neurophysiol. 1997 Sep;78(3):1468-75
references.pmid: 9310436
references.citation: J Neurosci. 1998 May 1;18(9):3386-403
references.pmid: 9547246
references.citation: J Physiol. 1999 Apr 1;516 ( Pt 1):227-48
references.pmid: 10066937
references.citation: Neuroscience. 2005;136(4):1003-14
references.pmid: 16226383
references.citation: J Physiol. 2002 Feb 1;538(Pt 3):773-86
references.pmid: 11826164
references.citation: Neuron. 1994 Feb;12(2):261-9
references.pmid: 8110457
references.citation: Curr Opin Neurobiol. 2009 Jun;19(3):245-53
references.pmid: 19559598
references.citation: Trends Neurosci. 2003 Nov;26(11):631-40
references.pmid: 14585604
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12450-5
references.pmid: 14519849
references.citation: Neuropharmacology. 1996 Jun;35(6):637-42
references.pmid: 8887973
references.citation: Neuroscience. 2007 Aug 10;148(1):7-21
references.pmid: 17630217
references.citation: Hippocampus. 2010 Sep;20(9):1003-9
references.pmid: 19830814
references.citation: Neurosci Lett. 1996 Mar 22;207(1):70-2
references.pmid: 8710213
references.citation: Neuron. 2000 Mar;25(3):663-72
references.pmid: 10774733
references.citation: J Neurophysiol. 1998 Jun;79(6):2903-10
references.pmid: 9636096
references.citation: Neuroscience. 2000;98(3):407-27
references.pmid: 10869836